People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arbovax, Inc. | — | Biotechnology | Seed | $3.4M | $75.3M | 2010 |
| Agile Sciences, Inc | — | Pharmaceuticals | Seed | $2.3M | $38.0M | 2020 |
Malcolm Thomas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Malcolm Thomas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Young | 1 | 6 |
| David LaVance | 1 | 4 |
| Jonathan Lawrie | 1 | 2 |
| Keith Stoneback | 1 | 2 |
| Jeremy Mario | 1 | 2 |
| Stephen Brand | 1 | 1 |
| Christian Melander | 1 | 1 |
| Harry Garland | 1 | 1 |
| Troy Knauss | 1 | 1 |
| Bill Culpepper | 1 | 1 |
| Herb Hugill | 1 | 1 |
| Leslie Alexandre | 1 | 1 |
| Charlton Owensby | 1 | 1 |
| John Cavanagh | 1 | 1 |
| Christopher English | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.